Ezetimibe Side Effects
Some side effects of ezetimibe may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to ezetimibe: oral tablet
Along with its needed effects, ezetimibe may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.Frequency not determined
- Abdominal fullness
- black tarry stools
- bleeding gums
- blood in urine or stools
- darkened urine
- fast heartbeat
- gaseous abdominal pain
- general tiredness or weakness
- large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, sex organs
- loss of appetite
- light-colored stools
- muscle cramps or spasms
- muscular tenderness, wasting or weakness
- pains in stomach, side or abdomen, possibly radiating to the back
- pinpoint red spots on skin
- recurrent fever
- severe nausea
- skin rash
- unusual bleeding or bruising
- upper right abdominal pain
- yellow eyes or skin
Some side effects of ezetimibe may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:More common
- muscle pain
- runny nose
- sore throat
- Back pain
- body aches or pain
- chest pain
- cold or flu-like symptoms
- difficulty in moving
- dryness or soreness of throat
- muscle pain or stiffness
- pain in joints
- pain or tenderness around eyes and cheekbones
- shortness of breath or troubled breathing
- stomach pain
- stuffy nose
- tender, swollen glands in neck
- tightness of chest or wheezing
- trouble in swallowing
- unusual tiredness or weakness
- voice changes
For Healthcare Professionals
Applies to ezetimibe: oral tablet
General side effects including fatigue (2.2%) have been reported.
Gastrointestinal side effects including diarrhea (3.7%) and abdominal pain (3.0%) have been reported. Pancreatitis and nausea have also been reported in postmarketing experience.
A case of ezetimibe-induced acute pancreatitis occurred two weeks after initiating therapy. Following discontinuation of ezetimibe the patient's symptoms resolved and pancreatic enzyme levels normalized.
Immunologic side effects including sinusitis (3.6%), pharyngitis (2.3%), and viral infection (2.2%) have been reported.
Musculoskeletal side effects including back pain (4.1%) and arthralgia (3.8%) have been reported. Other effects including myalgia, arthralgia, elevated creatine phosphokinase, and rare reports of myopathy/rhabdomyolysis have been reported in postmarketing experience.
Respiratory side effects including coughing (2.3%) have been reported.
Hypersensitivity reactions including angioedema, anaphylaxis, rash, urticaria, and erythema multiforme have been reported in postmarketing experience.
Hepatic side effects including elevations in liver transaminases, hepatitis, cholelithiasis, and cholecystitis have been reported in postmarketing experience.
Hematologic side effects including thrombocytopenia have been reported in postmarketing experience.
Nervous system side effects including dizziness, paresthesia, and headache have been associated with ezetimibe in postmarketing experience.
Psychiatric side effects including depression have been reported during the postmarketing experience.
More ezetimibe resources
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.